Trademark applications and grants for Obsidian Therapeutics Inc. Obsidian Therapeutics Inc has 17 trademark applications. The latest application filed is for "CYTOTIL15-LIGHT"
Patent Application | Date |
---|---|
CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION 20220267398 - 17/596277 OLS; Michelle Lynn ;   et al. | 2022-08-25 |
CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION 20220259284 - 17/596281 SCHEBESTA; Michael ;   et al. | 2022-08-18 |
DHFR TUNABLE PROTEIN REGULATION 20220213449 - 17/646212 SURI; Vipin ;   et al. | 2022-07-07 |
CD40L COMPOSITIONS AND METHODS FOR TUNABLE REGULATION 20220175781 - 17/436997 SCHEBESTA; Michael ;   et al. | 2022-06-09 |
COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF CAS NUCLEASES 20220170011 - 17/548076 INNISS; Mara Christine ;   et al. | 2022-06-02 |
SEC | 0001723046 | Obsidian Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.